Patent ID: 7230018

Claim:
A compound corresponding to formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 and R 2 together are —(CH 2 ) m — and form a ring in combination with the carbons to which R 1 and R 2 are connected in formula (I), where m=2, 3, 4, 5 or 6, wherein the —(CH 2 ) m — ring is optionally substituted one or more times by C 1-6 -alkyl, aryl, O—C 1-6 -alkyl, O—(C 1-6 -alkyl)-aryl, or benzo-fused; R 3 is selected from the group consisting of H, C 1-12 -alkyl, C 3-8 -cycloalkyl, aryl, —(C 1-6 -alkyl)-C 3-8 -cycloalkyl, —(C 1-6 -alkyl)-aryl, heterocyclyl, —(C 1-6 -alkyl)-heterocyclyl, and C(═O)—R 7 , R 4 is selected from the group consisting of H, C 1-12 -alkyl, C 3-8 -cycloalkyl, aryl, —(C 1-6 -alkyl)-C 3-8 -cycloalkyl, —(C 1-6 -alkyl)-aryl, heterocyclyl, and —(C 1-6 -alkyl)-heterocyclyl, R 5 and R 6 are independently selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, aryl, —(C 1-6 -alkyl)-C 3-8 -cycloalkyl, and (C 1-6 -alkyl)-aryl, and A is selected from the group consisting of aryl, heteroaryl, C(═O)OR 10 , and 2-propyl; wherein R 7 is selected from the group consisting of C 1-6 -alkyl, C 3-8 -cycloalkyl, aryl, heterocyclyl, —(C 1-6 -alkyl)-C 3-8 -cycloalkyl, —(C 1-6 -alkyl)-aryl, and —(C 1-6 -alkyl)-heterocyclyl; R 10 is selected from the group consisting of C 1-6 -alkyl, C 3-8 -cycloalkyl, aryl, —(C 1-6 -alkyl)-C 3-8 -cycloalkyl, and —(C 1-6 -alkyl)-aryl; wherein the compound corresponding to formula (I) is present as a racemate or in the form of one or more diastereomers or one or more enantiomers; and wherein the compound corresponding to formula (I) is not selected from benzyl-[2-(dimethylamino-phenyl-methyl)-cyclohexyl]-amine.